Going the distance: Nicola Freeman on her life-changing research and running the Brighton Marathon

The consultant head and neck radiographer tells Synergy about how photobiomodulation therapy is revolutionising radiotherapy, and why she decided to run a marathon in aid of Salivary Gland Cancer UK

By Marese O'Hagan

Nicola Freeman

Nicola Freeman

When Nicola Freeman attended the SoR’s Annual Radiotherapy Conference for the first time in October last year, she was struck by the opportunities to further educate herself. “I think when youve been in radiotherapy for 20-something years, you think are there any more things that you could learn?’” she says. “But there were lots of new topics that I had not heard of.”

Nicola – whose career spans 22 years – hoped that her presentation on photobiomodulation (PBM) therapy at the conference would be an opportunity for attendees to learn about an innovative, groundbreaking treatment for radiotherapy acute toxicities.

But what exactly is photobiomodulation therapy? And how did Nicola end up involved in implementing the device at Leicester?

Nicola Freeman

Nicola Freeman

When Nicola Freeman attended the SoR’s Annual Radiotherapy Conference for the first time in October last year, she was struck by the opportunities to further educate herself. “I think when youve been in radiotherapy for 20-something years, you think are there any more things that you could learn?’” she says. “But there were lots of new topics that I had not heard of.”

Nicola – whose career spans 22 years – hoped that her presentation on photobiomodulation (PBM) therapy at the conference would be an opportunity for attendees to learn about an innovative, groundbreaking treatment for radiotherapy acute toxicities.

But what exactly is photobiomodulation therapy? And how did Nicola end up involved in implementing the device at Leicester?

Reducing pain, improving healing

In Nicola’s words,

PBM therapy is given to patients undergoing treatment for head and neck cancers. It treats and prevents oral mucositis, a common side effect of radiotherapy and chemotherapy where the lining of the mouth becomes inflamed.

The therapy is administered through a device patients hold over their cheeks and lips, for one minute over each area. This is in combination with an intra-oral lollipop-type applicator on top of the tongue and underneath the tongue, also held for one minute each. In total, the treatment takes around five to seven minutes. “The red LED glows while the machine is switched on. The patient doesnt feel anything happening,” Nicola says, describing the PBM machine. “It is quick, painless and easy to use and makes a big difference to the prevention and treatment of oral mucositis in patients undergoing treatment for head and neck cancer.”

Working towards success

Nicola began her radiotherapy career in 2003 at the Leicester Royal Infirmary (LRI), where she has remained since. This followed three years of clinical placements at the hospital while she studied for her BSc with honours in radiotherapy and oncology. After earning her degree she worked in the radiotherapy department, becoming a senior radiographer after 18 months, and then moved up to become a team leader radiographer two years later.

In that role, Nicola took on a number of other responsibilities, such as becoming an undergraduate clinical placement facilitator for LRI placement students at Sheffield Hallam University. But it was her position as superintendent radiographer – which came eight years later – that gave her the opportunity to apply for a Macmillan-funded head and neck specialist radiographer role. “We applied for a funding bid with Macmillan Cancer Care to improve the pathway for complex tumour sites,” Nicola explains. “An opportunity arose, which was a 50/50 job share with another radiographer who was looking into the palliative radiotherapy pathway.”

After 18 months, the job became available as a full-time position. The role itself changed as Nicola gained more local in-house skills and completed her Masters in Advanced Clinical Practice Radiotherapy and Oncology at Sheffield Hallam University.

For the last two and a half years, Nicola has worked as a head and neck consultant radiographer at LRI. “Within [my masters] I completed independent prescribing and physical assessment and consultation skills,” Nicola says. “That allowed me to take on more of the role that traditionally would be undertaken by other medical professionals – the registrars and the consultants – to enable me then to provide efficient care for the patients as theyre on treatment.”

Nicola’s masters provided a defined pathway towards the advanced clinical practitioner pathway, then the consultant pathway. This then led to research opportunities within the consultant role, including introducing PBM therapy as a standard of care.

A large part of Nicola’s role nowadays requires her to manage patients acute toxicity. But this is more than monitoring dosages. At LRI, Nicola provides “practical, emotional and physical support for [patients] to make sure they get through treatment in the best condition they can”.

“We
ll try to optimise the physical, mental and practical aspects of their care,” she says. “And make sure thats as efficient as we can get it. That ultimately means they can recover much more effectively.

Prioritising emotional wellbeing

Patient wellbeing is of great importance to Nicola. It’s why she takes every opportunity to shout about PBM therapy, which can significantly ease the side effects of radiotherapy for head and neck cancer patients. “Radiotherapy is a very difficult treatment, but for the head and neck it affects many aspects of the persons life,” she says. “Not just their eating and their speech – it has a huge emotional toll.

“Theres a big burden not just on the patient, but also on the family. Meal times can be very difficult because they don’t produce enough saliva to be able to chew their food, their appetite is reduced and food has a nasty taste.”

Patients can also struggle with the textures and smells of food during treatment, causing them to withdraw from social occasions. “That focus on food, that becomes almost their nemesis, really,” Nicola explains. “Patients obviously get quite a high dose of radiation to their oral cavity, which then causes dryness and soreness, and a lot of pain can be associated with that.

“If we can minimise that in any way, and make that more comfortable for the patient, then it means they can eat for longer, they can potentially enjoy their food for longer and all of the emotional burden that comes with not being able to eat, drink, speak and communicate effectively is reduced. That has a huge impact on their emotional wellbeing as they’re going through the treatment.”

Assessing the impact

As part of her work at LRI, Nicola and her colleagues carried out an audit of one year’s worth of patients. They looked at 84 patients who had a variety of head and neck cancers and were being treated with radiotherapy, chemotherapy or surgery – and in some cases, all three. They assessed the patient’s toxicity scores and how their mucositis worsened throughout their treatment.

Nicola and Bilquis Musa, a senior radiographer at LRI, were responsible for data collection, while the department’s research radiographer, Alison Osborne, helped with data analysis and presentation. The patients used PBM in addition to caphosol mouthwash, which was the department’s standard treatment for mucositis.

The conclusion? With PBM, a patient’s strong opioid use could be reduced by close to 50 per cent. While less opioid use alone doesn’t significantly affect the NHS budget, patients could ultimately require less medication for other side effects in the future, meaning that the long-term effect is palpable. “The more medications patients require throughout the treatment, generally the more side effects from that medication they get,” Nicola explains.

Additionally, treating issues in the oral cavity means a patient can fuel themselves better. “If we can reduce that burden, make that more comfortable, then the patient has a better experience through the radiotherapy. But they will also have more calorie intake because they’re able to eat for longer, and it means that they will ultimately recover much more effectively. They’re not so tired for months and months.”

The PBM technology has been in the NHS for a number of years. It has been recommended by the National Institute for Health and Care Excellence since 2018 for the exact purpose Nicola treats patients for: oral mucositis. But not every treatment centre has the equipment needed to administer the therapy. The PBM machine used at LRI was purchased thanks to a charitable donation. It has been in use for two and a half years and has helped “hundreds and hundreds” of people so far, according to Nicola. Before it was introduced, she says LRI was prescribing a mouthwash for patients to help minimise oral mucositis. Now, with PBM in place, the hospital saves around £40,000 a year in mouthwash costs alone.

Working towards success

Nicola began her radiotherapy career in 2003 at the Leicester Royal Infirmary (LRI), where she has remained since. This followed three years of clinical placements at the hospital while she studied for her BSc with honours in radiotherapy and oncology. After earning her degree she worked in the radiotherapy department, becoming a senior radiographer after 18 months, and then moved up to become a team leader radiographer two years later.

In that role, Nicola took on a number of other responsibilities, such as becoming an undergraduate clinical placement facilitator for LRI placement students at Sheffield Hallam University. But it was her position as superintendent radiographer – which came eight years later – that gave her the opportunity to apply for a Macmillan-funded head and neck specialist radiographer role. “We applied for a funding bid with Macmillan Cancer Care to improve the pathway for complex tumour sites,” Nicola explains. “An opportunity arose, which was a 50/50 job share with another radiographer who was looking into the palliative radiotherapy pathway.”

After 18 months, the job became available as a full-time position. The role itself changed as Nicola gained more local in-house skills and completed her Masters in Advanced Clinical Practice Radiotherapy and Oncology at Sheffield Hallam University.

For the last two and a half years, Nicola has worked as a head and neck consultant radiographer at LRI. “Within [my masters] I completed independent prescribing and physical assessment and consultation skills,” Nicola says. “That allowed me to take on more of the role that traditionally would be undertaken by other medical professionals – the registrars and the consultants – to enable me then to provide efficient care for the patients as theyre on treatment.”

Nicola’s masters provided a defined pathway towards the advanced clinical practitioner pathway, then the consultant pathway. This then led to research opportunities within the consultant role, including introducing PBM therapy as a standard of care.

A large part of Nicola’s role nowadays requires her to manage patients acute toxicity. But this is more than monitoring dosages. At LRI, Nicola provides “practical, emotional and physical support for [patients] to make sure they get through treatment in the best condition they can”.

“We
ll try to optimise the physical, mental and practical aspects of their care,” she says. “And make sure thats as efficient as we can get it. That ultimately means they can recover much more effectively.

Prioritising emotional wellbeing

Patient wellbeing is of great importance to Nicola. It’s why she takes every opportunity to shout about PBM therapy, which can significantly ease the side effects of radiotherapy for head and neck cancer patients. “Radiotherapy is a very difficult treatment, but for the head and neck it affects many aspects of the persons life,” she says. “Not just their eating and their speech – it has a huge emotional toll.

“Theres a big burden not just on the patient, but also on the family. Meal times can be very difficult because they don’t produce enough saliva to be able to chew their food, their appetite is reduced and food has a nasty taste.”

Patients can also struggle with the textures and smells of food during treatment, causing them to withdraw from social occasions. “That focus on food, that becomes almost their nemesis, really,” Nicola explains. “Patients obviously get quite a high dose of radiation to their oral cavity, which then causes dryness and soreness, and a lot of pain can be associated with that.

“If we can minimise that in any way, and make that more comfortable for the patient, then it means they can eat for longer, they can potentially enjoy their food for longer and all of the emotional burden that comes with not being able to eat, drink, speak and communicate effectively is reduced. That has a huge impact on their emotional wellbeing as they’re going through the treatment.”

Assessing the impact

As part of her work at LRI, Nicola and her colleagues carried out an audit of one year’s worth of patients. They looked at 84 patients who had a variety of head and neck cancers and were being treated with radiotherapy, chemotherapy or surgery – and in some cases, all three. They assessed the patient’s toxicity scores and how their mucositis worsened throughout their treatment.

Nicola and Bilquis Musa, a senior radiographer at LRI, were responsible for data collection, while the department’s research radiographer, Alison Osborne, helped with data analysis and presentation. The patients used PBM in addition to caphosol mouthwash, which was the department’s standard treatment for mucositis.

The conclusion? With PBM, a patient’s strong opioid use could be reduced by close to 50 per cent. While less opioid use alone doesn’t significantly affect the NHS budget, patients could ultimately require less medication for other side effects in the future, meaning that the long-term effect is palpable. “The more medications patients require throughout the treatment, generally the more side effects from that medication they get,” Nicola explains.

Additionally, treating issues in the oral cavity means a patient can fuel themselves better. “If we can reduce that burden, make that more comfortable, then the patient has a better experience through the radiotherapy. But they will also have more calorie intake because they’re able to eat for longer, and it means that they will ultimately recover much more effectively. They’re not so tired for months and months.”

The PBM technology has been in the NHS for a number of years. It has been recommended by the National Institute for Health and Care Excellence since 2018 for the exact purpose Nicola treats patients for: oral mucositis. But not every treatment centre has the equipment needed to administer the therapy. The PBM machine used at LRI was purchased thanks to a charitable donation. It has been in use for two and a half years and has helped “hundreds and hundreds” of people so far, according to Nicola. Before it was introduced, she says LRI was prescribing a mouthwash for patients to help minimise oral mucositis. Now, with PBM in place, the hospital saves around £40,000 a year in mouthwash costs alone.

What’s next for PBM?

PBM therapy has provided positive outcomes for patients in active treatment for cancer. For Nicola, the next natural step is to roll it out to patients experiencing late effects from treatment. “Radiotherapy has some horrible side effects that can come back after several years,” she explains. “The patients just think it’s all behind them, and then maybe two, three years down the line they actually begin to experience late toxicity.”

These late effects can include fibrosis – a hardening and thickening of muscle tissue. For head and neck cancer patients, this can cause pain and stiffness and impact neck movement, speech and swallowing function. Nicola is currently working to establish a late effects clinic to address issues like these in patients with head and neck cancer. But PBM therapy isn’t exclusively offered to head and neck cancer patients. Cancer patients who experience dermatitis and lymphoedema – a common side effect of breast cancer treatment – can also benefit.

Theres a huge emotional burden, not just for [patients], but for their family as well

A marathon of epic proportions

Nicola herself has benefitted from PBM therapy, using the device to treat injuries picked up by her Brighton Marathon training regimen. “PBM also has huge benefits to reducing soft tissue inflammation, so it’s great for aching muscles.”

After being unable to secure a place in the London Marathon, Nicola was roped into taking part in the Brighton Marathon in aid of Salivary Gland Cancer UK by Emma Kinloch, co-founder and trustee of the charity. The marathon takes place on 6 April.

Salivary gland cancer has a particularly high level of recurrence. Where most cancer patients are followed up on for five years after treatment, this rises to 10 years for salivary gland cancer. “The treatment is generally surgery, possibly followed by radiotherapy,” Nicola tells Synergy. “But [the tumours] can come back, that
s the thing. Generally speaking, they can be indolent tumours. You can treat them, but the radiotherapy doesn’t work that effectively. But it can keep it at bay. Sadly, some types can be very aggressive.

“Everybody who undergoes cancer treatment will think ‘is it going to come back?’ Every time they have a scan, ‘is it going to come back?’ Every twinge, ‘is that the cancer coming back?’ But patients who have had a salivary gland cancer are told that it probably will come back at some point. And they will therefore have a longer surveillance period.”

While head and neck cancers are rare, salivary gland cancers are even more so, and Nicola wants to raise awareness among health professionals. “These patients will present to a health professional with a lump that might seem rare. It might seem random. It might seem that it’s probably not cancer, but we should be encouraging GPs, dentists and other practitioners that will see patients to think ‘could it be a head and neck cancer? Could it be a salivary gland cancer?’” There are 23 types of salivary gland cancer, and no approved drug therapies to treat them. One of the most common is adenoid cystic carcinoma, which has a high rate of metastases, and they can appear 10 to 20 years after successful treatment of the primary tumour.

Having run the Leicester Half Marathon with a former patient in 2023, Nicola knows what it will take to run twice the distance. But it’s all worth it to raise awareness for Salivary Gland Cancer UK, she says. “It will be great to raise awareness for them. That’s why I let Emma con me into it,” she jokes, “and I agreed to it because it’s a great charity. They work hard to advocate for patients with rare cancers, trying to get them more funding to research future treatment opportunities.”

Not only does the charity fundraise for salivary gland cancer, it also runs a biobank in collaboration with a medical oncologist at the Christie Hospital in Manchester. Patients that undergo surgery to remove a salivary gland tumour can choose to donate their tissue to the biobank if they wish, furthering research.

All for the patient’s benefit

Throughout her career, Nicola has consistently gained skills and expertise that help her go above and beyond for her patients. So it’s no surprise that she would run a marathon for charity – literally going the extra mile. And Nicola knows the positive effect she has on her patients by jointly managing their toxicity levels and prioritising emotional wellbeing. “They need a lot of extra care,” Nicola continues, referring to patients undergoing head and neck cancer treatment. “I like that I’m able to help with that. We have a unique skillset as radiographers and a very privileged position as consultant radiographers to support our patients throughout their journey.

“I know that my input, my skills and my expertise can make a huge difference to how that patient manages their toxicities throughout the treatment. And it means they could recover much better if I’m able to support them with efficient management of those toxicities.

“The skills that I’ve acquired throughout my training, the extra courses, the extra study that I’ve undertaken, allow me to facilitate them in a much better way.”

More about Salivary Gland Cancer UK

Salivary Gland Cancer UK is a charity for people with uncommon salivary gland cancers, including adenoid cystic carcinoma and acinic cell Ccarcinoma. The charity provides support for both patients and carers, as well as information on salivary gland cancers and treatment options. Salivary Gland Cancer UK also holds Salivary Gland Cancer Day, which takes place on 4 October

To find out more about Salivary Gland Cancer UK, click here.

To view Nicolas fundraising page, click here.

Video credit: Getty Images

Read more